Louis de Mestier Selected Research

Vipoma (WDHA)

12/2021	Efficacy of treatments for VIPoma: A GTE multicentric series.
1/2015	Sunitinib achieved fast and sustained control of VIPoma symptoms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Louis de Mestier Research Topics

Disease

25	Neoplasms (Cancer) 12/2021 - 01/2012
15	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2022 - 06/2014
9	Adenocarcinoma 05/2021 - 11/2015
7	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2012
3	Primitive Neuroectodermal Tumors (PNET) 12/2021 - 05/2015
3	Carcinoid Tumor (Carcinoid) 01/2021 - 09/2014
2	Vipoma (WDHA) 12/2021 - 01/2015
2	Hemorrhage 11/2020 - 01/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 10/2019
2	Carcinogenesis 01/2017 - 02/2014
1	Multiple Endocrine Neoplasia Type 1 01/2022
1	Carcinoma (Carcinomatosis) 02/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Neuroendocrine Carcinoma 01/2021
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2021
1	Necrosis 01/2021
1	Incisional Hernia 01/2020
1	Pancreatitis 10/2019
1	Exocrine Pancreatic Insufficiency 10/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Intestinal Neoplasms (Intestinal Cancer) 01/2018
1	Stomach Neoplasms (Stomach Cancer) 09/2016
1	Diarrhea 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 04/2013
1	Adenoma (Adenomas) 06/2012
1	Rectal Neoplasms (Rectal Cancer) 06/2012
1	Anemia 01/2012
1	Peritoneal Neoplasms 01/2012
1	Ascites 01/2012

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 02/2021 - 05/2015
7	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2022 - 01/2012
3	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 12/2021 - 01/2015
3	Gemcitabine FDA Link 05/2021 - 11/2019
3	Temozolomide (Temodar)FDA LinkGeneric 10/2020 - 01/2019
3	Biological ProductsIBA 01/2020 - 06/2014
2	lanreotide (Somatuline)FDA Link 01/2022 - 01/2021
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2022 - 01/2018
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2022 - 01/2021
2	Sunitinib (Sutent)FDA Link 12/2021 - 01/2015
2	Everolimus FDA Link 12/2021 - 01/2016
2	Alkylating AgentsIBA 11/2021 - 10/2020
2	130-nm albumin-bound paclitaxelIBA 05/2021 - 01/2020
2	PlatinumIBA 02/2021 - 01/2021
2	Etoposide (VP 16)FDA LinkGeneric 02/2021 - 01/2021
2	Dacarbazine (DIC)FDA LinkGeneric 10/2020 - 01/2019
2	Capecitabine (Xeloda)FDA Link 01/2020 - 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 11/2021
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2021
1	AntigensIBA 01/2021
1	AutoantibodiesIBA 01/2021
1	ChromatinIBA 01/2021
1	AcidsIBA 01/2021
1	Blood Group Antigens (Blood Groups)IBA 12/2020
1	ABO Blood-Group SystemIBA 12/2020
1	Streptozocin (Streptozotocin)FDA Link 10/2020
1	folfirinoxIBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Polyglactin 910IBA 01/2020
1	NucleosidesIBA 11/2019
1	Kazal Pancreatic Trypsin InhibitorIBA 10/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	inositol polyphosphate multikinaseIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Glucagon (Glukagon)FDA Link 05/2015
1	Insulin (Novolin)FDA Link 05/2015
1	Peptides (Polypeptides)IBA 05/2015
1	GastrinsIBA 05/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2014
1	MitogensIBA 02/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2014
1	Phosphotransferases (Kinase)IBA 02/2014
1	GuaiacIBA 06/2012
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 01/2012

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 12/2021 - 01/2012
12	Therapeutics 12/2021 - 06/2012
1	Pancreatectomy 01/2021
1	Ovariectomy (Oophorectomy) 01/2021
1	Hepatectomy 01/2021
1	Aftercare (After-Treatment) 11/2020
1	Radiotherapy 11/2020
1	Combination Drug Therapy (Combination Chemotherapy) 11/2020
1	Neoadjuvant Therapy 12/2019
1	Induction Chemotherapy 06/2015
1	Biological Therapy 04/2013
1	Chemoradiotherapy 06/2012
1	Blood Transfusion (Blood Transfusions) 01/2012
1	Hyperthermic Intraperitoneal Chemotherapy 01/2012